Author Topic: (ECTRIMS) 2-year Ocrevus effective for early MS patients  (Read 34 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9816
  • MS diagnosed 1980
  • Location: Pacific Northwest
(ECTRIMS) 2-year Ocrevus effective for early MS patients
« on: October 26, 2022, 06:42:44 pm »
This is a drug-company-sponsored study, and it deals with only 2 years after initiating treatment with Ocrevus, but the account of this presentation at the annual ECTRIMS conference (October 26-28) has been getting some media attention.


From Multiple Sclerosis News Today (October 26, 2022)--"#ECTRIMS2022: 2-Year Ocrevus Effective for Early MS Patients":





https://bit.ly/3zjDnOH
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
149 Views
Last post September 16, 2016, 11:36:28 am
by agate
1 Replies
205 Views
Last post February 19, 2017, 03:09:05 pm
by agate
1 Replies
147 Views
Last post September 19, 2019, 07:44:56 pm
by agate
0 Replies
37 Views
Last post December 27, 2019, 09:35:04 pm
by agate
0 Replies
15 Views
Last post October 13, 2023, 08:41:51 pm
by agate